LITS
NASDAQ
$1.03
Lite Strategy Inc (LITS)
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$35M
P/B Ratio
0.60
Free Cash Flow Yield
-29.96%
Beta (5Y)
1.47
Price Chart
Valuation
Market Cap$35M
Forward P/E4.62
PEG2.22
P/S0.31
P/B0.60
Profitability
Total Revenue (TTM)$114K
Gross Profit (TTM)-$1.97M
EBITDA-$62M
EPS-$1.76
Financial Health
Free Cash Flow Yield-29.96%
Growth & Risk
EPS 5Y CAGR-11.11%
Revenue 5Y CAGR-67.29%
Beta (5Y)1.47
Sharpe Ratio-1.17